IDXX

#329
Idexx Laboratories Inc
582.56 USD
+1.49%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
581.22
583.70
Rango anual
398.75
769.98
Cambio diario
+1.49%
Variación mensual
-0.01%
Variación en los últimos 6 meses
-9.00%
Cambio anual
+43.73%
Cierres anteriores
574.00
Abrir
583.46
Bid
Ask
Mínimo
581.22
High
583.70
Volumen
130
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 46.39 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
51.72
Relación precio/flujo de caja
12.76

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

Noticias